A Novel Inhibitor of Oxidosqualene: Lanosterol Cyclase Inhibits Very Low-Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content

D.E. Telford, S.M. Lipson, Hugh Barrett, B.C. Sutherland, J.Y. Edwards, J.D. Aebi, H. Dehmlow, O.H. Morand, M.W. Huff

    Research output: Contribution to journalArticlepeer-review

    19 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'A Novel Inhibitor of Oxidosqualene: Lanosterol Cyclase Inhibits Very Low-Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content'. Together they form a unique fingerprint.

    Medicine & Life Sciences